Antigen-specific T cells in rheumatoid arthritis Sean R. BennettMichael T. FaltaBrian L. Kotzin OriginalPaper Pages: 255 - 263
B lymphocytes and systemic lupus erythematosus Lisa G. CriscioneDavid S. Pisetsky OriginalPaper Pages: 264 - 269
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis Ted R. MikulsArthur L. Weaver OriginalPaper Pages: 270 - 277
Atherosclerotic cardiovascular disease in rheumatoid arthritis Inmaculada del RincónAgustín Escalante OriginalPaper Pages: 278 - 286
Early rheumatoid arthritis: Toward tailor-made therapy Robert B. M. LandewéDésirée M. F. M. van der Heijde OriginalPaper Pages: 287 - 293
The laryngeal and esophageal manifestations of Sjögren’s syndrome Peter C. BelafskyGregory N. Postma OriginalPaper Pages: 297 - 303
The oral component of Sjögren’s syndrome: Pass the scalpel and check the water Ava J. Wu OriginalPaper Pages: 304 - 310
Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome Roland JonssonTom P. GordonYrjö T. Konttinen OriginalPaper Pages: 311 - 316
Lymphoproliferation in autoimmunity and Sjögren’s syndrome Michalis VoulgarelisHaralampos M. Moutsopoulos OriginalPaper Pages: 317 - 323
The genetics of primary Sjögren’s syndrome Amr H. SawalhaRobyn PottsJohn B. Harley OriginalPaper Pages: 324 - 332